Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bharat Biotech
Pharma
AstraZeneca's COVID nasal vax flunks Oxford study
AstraZeneca's COVID-19 nasal spray candidate has come up short in an early-stage trial, failing to produce a strong immune response.
Kevin Dunleavy
Oct 11, 2022 10:10am
Ocugen sniffs out COVID opportunity, landing nasal vaccine
Oct 4, 2022 7:05am
Ocugen gets OK from FDA to resume trial of its COVID-19 vaccine
May 23, 2022 9:09am
COVID tracker: FDA breathalyzer nod, Pfizer, Moderna, and more
Apr 13, 2022 10:55am
Ocugen, Bharat get another clinical hold from FDA on COVID vax
Apr 12, 2022 4:03pm
COVID-19 tracker: New variant, J&J, boosters and more
Nov 29, 2021 10:00am